 Home > Active Ingredient News > Antitumor Therapy > Int J Radiat Oncol Biol Phys: How effective is IVH with or without brachytherapy in patients with very high-risk prostate cancer?

Int J Radiat Oncol Biol Phys: How effective is IVH with or without brachytherapy in patients with very high-risk prostate cancer?

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

1 3 generator

high compression engine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Very high-risk (VHR) prostate cancer (PC) is an aggressive subgroup with a high risk of long-range progression in which systematic intensive therapy with abiraterone or docetaxel reduces specific mortality (PCSM) and distal metastases (DM) in men receiving in vitro irradiation radiation therapy (EBRT)

Recently, researchers from Canada published an article in Int J Radiat Oncol Biol Phys investigating

The study cohort came from 16 centers in 4 countries and included men with VHR PC who

The findings suggest that across the cohort, 270 people received EBRT and 101 received EBRT+BT

A specific cause Cox proportional risk model assesses prostate-specific survival and long-distance metastasis

In summary, no clinically significant difference

Original Source:

Sagar A Patel ， Ting Martin Ma ， Jessica K Wong et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.